Pharmaceutical Executive February 14, 2025
Mike Hollan

James Foster, CEO and co-founder of Virax Biolabs, discusses how the industry is preparing for potential regulatory changes to vaccine policy.

Pharmaceutical Executive: Due to recent political turbulence, many companies feel like they are facing uncertain regulatory environments. How can they strategize for that?
James Foster: We’re, relatively speaking, a small firm, so we’re able to stay nimble. As a result of that, we can move with the punches, so to speak. But I think a lot of from an executive perspective, and the way that we have to look at things is you have to strategize around particular events potentially occurring.

This tariff event, if we want to talk about that specifically, is something that we’ve strategized over the past...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Interview / Q&A, Pharma, Pharma / Biotech, Trends
Once high-flying Bluebird Bio sells itself to private equity after tough times for the gene therapy maker
Walgreens PE deal back on the table: 5 things to know
Stakeholder Management and Interoperability of Biosimilars
Anne Wojcicki has a new offer to take 23andMe private, this time for $74.7 million
Pharma Pulse 2/21/25: RWE in Medical Research and Drug Development, Inhaled Antibody Therapy for RSV & more

Share This Article